VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $475,231 | -14.7% | 17,660 | -4.6% | 0.04% | -9.8% |
| Q2 2023 | $557,337 | -8.4% | 18,510 | -1.6% | 0.04% | -12.8% |
| Q1 2023 | $608,504 | +17.8% | 18,810 | +4.3% | 0.05% | +14.6% |
| Q4 2022 | $516,740 | +18.0% | 18,030 | -0.7% | 0.04% | +7.9% |
| Q3 2022 | $438,000 | -18.6% | 18,160 | -7.5% | 0.04% | -9.5% |
| Q2 2022 | $538,000 | -30.6% | 19,640 | -2.8% | 0.04% | -20.8% |
| Q1 2022 | $775,000 | +19.4% | 20,215 | -0.3% | 0.05% | +23.3% |
| Q4 2021 | $649,000 | -21.8% | 20,275 | -28.0% | 0.04% | -27.1% |
| Q3 2021 | $830,000 | -7.9% | 28,170 | +6.2% | 0.06% | -9.2% |
| Q2 2021 | $901,000 | +7.4% | 26,525 | +2.7% | 0.06% | -1.5% |
| Q1 2021 | $839,000 | -4.0% | 25,820 | +6.4% | 0.07% | -9.6% |
| Q4 2020 | $874,000 | +21.9% | 24,256 | +32.5% | 0.07% | +9.0% |
| Q3 2020 | $717,000 | +197.5% | 18,311 | +179.1% | 0.07% | +168.0% |
| Q2 2020 | $241,000 | – | 6,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |